drugset
drugset / Trial / NCT03534648

Evaluation of Pharmacokinetic Drug Drug Interaction Between PF-05221304 And PF-06865571 In Healthy Adult Subjects

NCT03534648 ↗

Phase 1 Completed 16 enrolled Pfizer
Non-randomizedSequentialOpen-labelBasic science

Summary

Drug drug interaction study between PF-05221304 and PF-06865571

Timeline

Start
2018-04-19
Primary completion
2018-07-16
Completion
2018-08-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Clesacostat Small molecule — —
Subject PF-06865571 Small molecule — —

Indications

No indication recorded.